GR3035287T3 - Insulin and amylin containing composition for the treatment of insulin deficient mammals. - Google Patents

Insulin and amylin containing composition for the treatment of insulin deficient mammals.

Info

Publication number
GR3035287T3
GR3035287T3 GR20010400101T GR20010400101T GR3035287T3 GR 3035287 T3 GR3035287 T3 GR 3035287T3 GR 20010400101 T GR20010400101 T GR 20010400101T GR 20010400101 T GR20010400101 T GR 20010400101T GR 3035287 T3 GR3035287 T3 GR 3035287T3
Authority
GR
Greece
Prior art keywords
insulin
amylin
treatment
containing composition
deficient mammals
Prior art date
Application number
GR20010400101T
Other languages
English (en)
Inventor
Timothy J Rink
Andrew A Young
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Publication of GR3035287T3 publication Critical patent/GR3035287T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR20010400101T 1991-05-24 2001-01-24 Insulin and amylin containing composition for the treatment of insulin deficient mammals. GR3035287T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70499591A 1991-05-24 1991-05-24
PCT/US1992/004351 WO1992020366A1 (en) 1991-05-24 1992-05-23 Insulin and amylin containing composition for the treatment of insulin deficient mammals

Publications (1)

Publication Number Publication Date
GR3035287T3 true GR3035287T3 (en) 2001-04-30

Family

ID=24831674

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400101T GR3035287T3 (en) 1991-05-24 2001-01-24 Insulin and amylin containing composition for the treatment of insulin deficient mammals.

Country Status (11)

Country Link
EP (1) EP0586592B1 (el)
JP (1) JPH06510753A (el)
AT (1) ATE197764T1 (el)
AU (2) AU2169392A (el)
CA (1) CA2109604A1 (el)
DE (1) DE69231583T2 (el)
DK (1) DK0586592T3 (el)
ES (1) ES2153828T3 (el)
GR (1) GR3035287T3 (el)
SG (1) SG44838A1 (el)
WO (1) WO1992020366A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69221725T2 (de) * 1991-05-24 1997-12-18 Amylin Pharmaceuticals, Inc., San Diego, Calif. Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
EP1196189A2 (en) 1999-06-25 2002-04-17 Medtronic MiniMed, Inc. Multiple agent diabetes therapy
WO2002067969A2 (en) 2001-02-21 2002-09-06 Medtronic Minimed, Inc. Stabilized insulin formulations
US6737401B2 (en) 2001-06-28 2004-05-18 Metronic Minimed, Inc. Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
GB8915712D0 (en) * 1989-07-08 1989-08-31 Macintyre Iain Medical treatment

Also Published As

Publication number Publication date
CA2109604A1 (en) 1992-11-26
ES2153828T3 (es) 2001-03-16
DE69231583T2 (de) 2001-03-29
ATE197764T1 (de) 2000-12-15
AU2169392A (en) 1992-12-30
SG44838A1 (en) 1997-12-19
DE69231583D1 (de) 2001-01-04
AU6196496A (en) 1996-10-10
DK0586592T3 (da) 2000-12-27
EP0586592B1 (en) 2000-11-29
EP0586592A1 (en) 1994-03-16
JPH06510753A (ja) 1994-12-01
WO1992020366A1 (en) 1992-11-26

Similar Documents

Publication Publication Date Title
GR3001151T3 (en) Dressing for the treatment of wounds and manufacturing process
GEP19981274B (en) Urinary follicle stimulating hormone, pharmaceutical composition, component of pharmaceutical composition
IL98258A0 (en) Composition for treating impotence containing doxazosin,amlodipine,or u.k.52,046
GR3007092T3 (el)
ZA858105B (en) A pharmaceutical composition and a method of treating the body
IN166787B (el)
GB9517443D0 (en) Increasing creatine and glycogen concentration in muscle
ES2010561A6 (es) Procedimiento para preparar una composicion farmaceutica a base de un analogo de somatostatina.
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
GR3031129T3 (en) Enhancement of glutathione levels with glutamine
EP0981360A4 (en) METHOD FOR PREVENTING GASTRITIS USED BY AMYLIN OR AMYLIN AGONISTS
GR860900B (en) Amino-propanol derivatives method for their preparation their use and medicaments containing them
IL103383A0 (en) Pharmaceutical compositions containing glutamine and methods for the use thereof
ES2002083A6 (es) Un metodo para preparar derivados de piroglutamida
GR3035287T3 (en) Insulin and amylin containing composition for the treatment of insulin deficient mammals.
KR880012235A (ko) 정상 포유동물의 헤마토크릿을 증가시키는 방법
EP0313654A4 (en) MEDICINAL PRODUCTS FOR PROPHYLAXIS AND TREATMENT OF LIVER DISEASES.
IL86928A (en) Castanospermine esters and glycosides,their preparation and compositions containing them for treating diabetes and postprandial hyperglycemia
EP0285441A3 (en) Synergistic immunostimulating composition and method
GR1002317B (el) Προαγωγη της αναπτυξεως χοιρων.
PT85950A (en) Process for the preparation of protamine zinc insulin compositions useful for treating diabetes
CA2010054A1 (en) Method of weight control by low level administration of cobalt protoporphyrin or cobalt mesoporphyrin
AU6978887A (en) Method and compositions for increasing mammary parenchyma
EP0669832A1 (en) METHOD FOR TREATING OR PREVENTING OBESITY.
EP0308717A3 (en) Method of treating viral encephalitis